Peter Harf is a German entrepreneur and businessperson who founded 5 companies, which include: Coty, Inc., Delete Blood Cancer and DKMS Foundation and who has been the head of 21 different companies. Dr. Harf holds the position of Chairman & Chief Executive Officer of Joh. A. Benckiser GmbH, Managing Director at Lucresca SE, Managing Director at Agnaten SE, Chairman at Bally UK Sales Ltd., Chairman & Managing Partner at JAB Holding Co. SARL, Chairman & Chief Executive Officer for Coty, Inc. (which he founded in 1996), Chairman at Coty Italia SRL, Chairman & Managing Partner at JAB Holding Co. LLC, Chief Executive Officer for Parentes SE, Chairman-Management Board at JAB Luxury GmbH and Chief Executive Officer of Donata Holding SE (which are all subsidiaries of Agnaten SE) and Chairman of Bally International AG. Peter Harf is also Executive Chairman of Delete Blood Cancer (he founded the company) and Chairman at Deutsche Stiftung Leben Spenden (he founded the company in 1997) and on the board of 12 other companies.
In his past career Dr. Harf held the position of Chairman for Anheuser-Busch InBev SA, Principal at The Boston Consulting Group, Inc., Chairman at Espresso House Holding AB, Chairman of Belstaff Group SA, Non-Executive Chairman at Jimmy Choo Group Ltd., Chairman of Espresso House Sweden AB, Chief Executive Officer of JAB Holdings II BV, Senior Vice President-Corporate Planning at AEG AG and Executive Chairman for DKMS gemeinnützige GmbH (he founded the company in 2004).
Peter Harf received a doctorate from Universität zu Köln and an MBA from Harvard Business School.